Article

#21: Corneal Inlays for Presbyopia

Corneal inlays are a newer option for correction of decreased near vision in presbyopic individuals who desire improved spectacle-independent vision at all distances.

Corneal inlays are a newer option for correction of decreased near vision in presbyopic individuals who desire improved spectacle-independent vision at all distances.

Because corneal inlays are placed within the cornea, these are less surgically invasive than lens-based procedures. In addition, corneal inlays do not involve excimer laser ablation and no corneal tissue is consequently removed during their implantation. This is particularly relevant in patients whose corneas are too thin for LASIK or PRK (photorefractive keratectomy) procedures.

Another advantage of corneal inlays is that these can be easily explanted if patients are dissatisfied with the impact on their vision, returning them to or near their quality of vision before the implantation.

The Kamra inlay shown beside a contact lensCorneal inlays work by increasing the depth of focus or the refractive power of the central or paracentral part of the cornea. In some studies, corneal inlays have been combined with LASIK procedures to correct ametropia as either a simultaneous procedure or a 2-staged procedure. Corneal inlays are typically implanted into a patient’s nondominant eye only.

The first corneal inlay, the KAMRA™ inlay, was approved by the US Food and Drug Administration in April 2015. The KAMRA inlay is an opaque, ring-shaped inlay made of polyvinylidene fluoride and carbon. Two additional inlays, the Raindrop® Near Vision Inlay and the Flexivue Microlens™, are approved for use in Europe and are currently in the process of seeking regulatory approval in the United States. 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.